Indication
Burkholderia cepacia infection
1 clinical trial
1 product
Clinical trial
The Feasibility of Ceftolozane/Tazobactam Continuous Infusion for Exacerbations of Cystic Fibrosis and Bronchiectasis Treated in an Outpatient Parenteral Antibiotic Therapy (OPAT) SettingStatus: Not yet recruiting, Estimated PCD: 2023-10-01
Product
Ceftolozane/tazobactam